CTMX.OQ - CytomX Therapeutics Inc
Guggenheim Securities LLC
CTMX - BUY - Varseta-M Update Confirms Potl. Best-in-Class Efficacy in Late-Stage CRC; Encouraging Improvement in GI Tolerability with Dose-Optimization
公司
CTMX.OQ
日期
2026-03-16
分析师
Michael Schmidt, PHD
页数
6 页
需要登录
请登录后购买研报或生成音频内容。